AIM Breakfasts

AIM BREAKFAST – 14th December 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 988

Total number of AIM Companies trading: 960*
* As at 13 December 2016

Dish of the Day:

ECSC—admission to AIM of cyber security services provider. £5.9m raised at 167p. £15m mkt cap.  FY Sep 15 revenues £2.7m.

Off the Menu:

No AIM Leavers Today

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): 84*

Total number of ISDX Growth Market Companies trading: 81*
* As at 13 December 2016

Dish of the Day:

No ISDX Growth Market Joiners Today

Off the Menu:

No ISDX Growth Market Leavers Today

What’s Cooking in the IPO Kitchen?

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

Breakfast Buffet

MediaZest* (MDZ.L) 0.16p £1.92m

HYSep16 results from the creative media agency and audio visual systems integrator. Gross profit up 2% to £631k off reduced revenue (-8%) of £1.47m. Margin increase (43% vs 39%) helped by delivery of full service offering. EBITDA profit of £4k. Cash in hand of £137k up from £36k. Pilots to commence in  calendar Q1 2017  for two inter-related potential transformational projects. If successful expected to move forward and help generate material growth in revenues in the next financial year, 2017-18.

 

BOS Global (BOS.L) 10.13p £5.4m

Operational update and 2017 outlook from the software company focused on creating enterprise productivity solutions for the global workforce market. R&D work on the Company’s BOS360 Work Patterns product is ongoing. BOS anticipates that, subject to Australian government approval, it will recover up to 43% of its total R&D expenditure each year as income received under the Australian tax rebate incentive scheme. BOS Meet scheduled for launch on 15 December. A further three products are expected to be ready for commercial sale in January, with the BOS360 Work Patterns system available for commercial release in May 2017, to be complemented with an additional BOS owned product, BOS Time.

 

Free Agent Hldgs (FREE.L) 82p £33.3m

HY Sep16 results from the provider of cloud-based Software-as-a-Service accounting software. Revenue increased by 36% to £3.6 m.  Gross Profit up 38% to £3.0m. Annualised committed monthly recurring revenue  up 35% at £7.7m. Post period  successful placing of £8 million of new equity and admission to AIM in November 2016.  Confident of reporting further significant progress within its full-year results, consistent with market expectations.  However we can see no forecasts in the market.

 

Ilika (IKA.L) 44p £34.5m

The pioneer in materials innovation and solid-state battery technology, announced a collaborative project with McLaren Applied Technologies and Sharp Laboratories of Europe (Sharp) to create an autonomous energy harvesting power source, thanks to funding of over £500,000 from Innovate UK.  Over £320,000 of the Innovate UK grant will be provided to Ilika, to lead a two-year project which will see Ilika’s Stereax solid-state battery technology integrated with Sharp’s photovoltaic technology to provide a power source for McLaren Applied Technologies’ wireless sensing platform.  FYApr17E rev of £2.5m and £2.3m PBT loss.

boohoo.com (BOO.L) 118.25p £1.33bn

The online fashion retailer, has continued to perform well since reporting  Interims. Trading was strong across the Black Friday weekend & peak season trading continues to be encouraging. Board expects boohoo to deliver revenue growth of between 38% & 42% in FY17, vs prior guidance of  30% to 35%. The Board anticipates an EBITDA margin of between 11% and 12% in FY17, vs prior guidance of c.11%. Has also acquired 66% of PrettyLittleThing for £3.3m, whose revenue grew 400% to £17m in FY Feb16.

 

Hunters Property (HUNT.L) 65.5p £18.76m

Trading update from one of the UK’s largest national sales and lettings agency and franchise businesses.  Strong performance has continued into H2, despite the well-publicised uncertainty in the UK housing market in the wake of the government’s changes to stamp duty earlier in the year and the UK’s decision to leave the EU.  The Board expects trading for the full year to be significantly ahead of last year and slightly ahead of the Board’s expectations.  There are no forecasts in the market.

 

Audioboom Group (BOOM.L) 2.13p £13.56m

The spoken-word audio on-demand platform, has updated on its Q4 KPIs and trading for the year ended 30 November 2016. Overall 2016 revenues are expected to exceed £1.3 million, an increase of more than six fold compared to last year, and ahead of market expectations. This rate of revenue growth has continued post year end, with over £1.1 million already booked for advertising campaigns in 2017.  Record Q4 unique file requests up 42% over Q3 to 145m. 9527 content channels at period end up 38% year on year. FY17E rev of £5.23m and pre-tax loss of £2.3m.

 

TP Group (TPG.L) 5.12p £21.65m

Trading update from the  specialist services and engineering group. FYDec16 EBITDA likely to significantly exceed current market expectations with FY17 materially ahead of current market expectations, primarily to recent contract wins and a strong order pipeline (including the two sole source MoD contracts announced in July and August 2016). The management will also continue to look for acquisition opportunities. FYDec16E rev £22.6m and PBT loss of £0.46m. FY17E rev £24.8m, £0.73m PBT.

 

Victoria (VCP.L) 343p £312m

The international designers, manufacturers and distributors of innovative floor coverings,  has agreed to acquire the business and assets of Dunlop Flooring, the Australian underlay and hard wood flooring manufacturer and distributor, for a cash consideration of A$34 million (£20 million), which will be funded from the Company’s cash and existing debt facilities. The Acquisition will be immediately and significantly earnings accretive on completion. FYMar17E rev of £318m and £28m PBT.

 

Plant Health Care (PHC.L) 14p £20m

The provider of novel patent-protected biological products to global agriculture markets, has announced four new commercial distribution arrangements, which together represent important progress in driving sales growth in 2017 and beyond. The agreements cover multiple products and territories (USA, Sub Saharan Africa and Portugal). FYDec17E revenues of £8.25m and £6m and £4.9m pre-tax loss.

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.